Literature DB >> 25579084

Organization for rare diseases India (ORDI) - addressing the challenges and opportunities for the Indian rare diseases' community.

Harsha Karur Rajasimha1, Prasannakumar Basayya Shirol1, Preveen Ramamoorthy1, Madhuri Hegde1, Sangeeta Barde1, Vijay Chandru1, M E Ravinandan1, Ramani Ramchandran2, Kasturi Haldar3, Jimmy C Lin4, Imran A Babar4, Katta M Girisha5, Sudha Srinivasan6, Duraiswamy Navaneetham7, Rajani Battu8, Rajashree Devarakonda9, Usha Kini10, Kinnimulki Vijayachandra11, Ishwar C Verma12.   

Abstract

In order to address the unmet needs and create opportunities that benefit patients with rare disease in India, a group of volunteers created a not-for-profit organization named Organization for Rare Diseases India (ORDI; www.ordindia.org). ORDI plans to represent the collective voice and advocate the needs of patients with rare diseases and other stakeholders in India. The ORDI team members come from diverse backgrounds such as genetics, molecular diagnostics, drug development, bioinformatics, communications, information technology, patient advocacy and public service. ORDI builds on the lessons learned from numerous similar organizations in the USA, European Union and disease-specific rare disease foundations in India. In this review, we provide a background on the landscape of rare diseases and the organizations that are active in this area globally and in India. We discuss the unique challenges in tackling rare diseases in India, and highlight the unmet needs of the key stakeholders of rare diseases. Finally, we define the vision, mission, goals and objectives of ORDI, identify the key developments in the health care context in India and welcome community feedback and comments on our approach.

Entities:  

Mesh:

Year:  2014        PMID: 25579084      PMCID: PMC7044965          DOI: 10.1017/S0016672314000111

Source DB:  PubMed          Journal:  Genet Res (Camb)        ISSN: 0016-6723            Impact factor:   1.588


  10 in total

1.  Epidemiology of rare diseases in Brazil: protocol of the Brazilian Rare Diseases Network (RARAS-BRDN).

Authors:  Têmis Maria Félix; Bibiana Mello de Oliveira; Milena Artifon; Isabelle Carvalho; Filipe Andrade Bernardi; Ida V D Schwartz; Jonas A Saute; Victor E F Ferraz; Angelina X Acosta; Ney Boa Sorte; Domingos Alves
Journal:  Orphanet J Rare Dis       Date:  2022-02-24       Impact factor: 4.123

2.  Medical genetics and genomic medicine in India: current status and opportunities ahead.

Authors:  Shagun Aggarwal; Shubha R Phadke
Journal:  Mol Genet Genomic Med       Date:  2015-05       Impact factor: 2.183

3.  Orphan drugs: Indian perspective.

Authors:  Harish Kumar; Phulen Sarma; Bikash Medhi
Journal:  Indian J Pharmacol       Date:  2017 Jul-Aug       Impact factor: 1.200

4.  The promise of discovering population-specific disease-associated genes in South Asia.

Authors:  Nathan Nakatsuka; Priya Moorjani; Niraj Rai; Biswanath Sarkar; Arti Tandon; Nick Patterson; Gandham SriLakshmi Bhavani; Katta Mohan Girisha; Mohammed S Mustak; Sudha Srinivasan; Amit Kaushik; Saadi Abdul Vahab; Sujatha M Jagadeesh; Kapaettu Satyamoorthy; Lalji Singh; David Reich; Kumarasamy Thangaraj
Journal:  Nat Genet       Date:  2017-07-17       Impact factor: 38.330

Review 5.  Genomics of rare genetic diseases-experiences from India.

Authors:  Sridhar Sivasubbu; Vinod Scaria
Journal:  Hum Genomics       Date:  2019-09-25       Impact factor: 4.639

6.  The work, goals, challenges, achievements, and recommendations of orphan medicinal product organizations in India: an interview-based study.

Authors:  Mohua Chakraborty Choudhury; Gayatri Saberwal
Journal:  Orphanet J Rare Dis       Date:  2019-11-04       Impact factor: 4.123

Review 7.  Review: Understanding Rare Genetic Diseases in Low Resource Regions Like Jammu and Kashmir - India.

Authors:  Arshia Angural; Akshi Spolia; Ankit Mahajan; Vijeshwar Verma; Ankush Sharma; Parvinder Kumar; Manoj Kumar Dhar; Kamal Kishore Pandita; Ekta Rai; Swarkar Sharma
Journal:  Front Genet       Date:  2020-04-30       Impact factor: 4.599

8.  Uncommon ophthalmology - Care for the rare.

Authors:  Santosh G Honavar
Journal:  Indian J Ophthalmol       Date:  2022-07       Impact factor: 2.969

9.  Financing of Rare Diseases and Orphan Drugs in A Sanctioned Country: A Qualitative Study.

Authors:  Seyran Naghdi; Mohammadreza Maleki; Sudabeh Vatankhah
Journal:  Med J Islam Repub Iran       Date:  2022-05-11

10.  A questionnaire-based study to comprehensively assess the status quo of rare disease patients and care-givers in China.

Authors:  Xuefeng Li; Meiling Liu; Jinduan Lin; Bingzhe Li; Xiangyu Zhang; Shu Zhang; Zijuan Lu; Jianyong Zhang; Jincheng Zhou; Li Ou
Journal:  Orphanet J Rare Dis       Date:  2021-07-22       Impact factor: 4.123

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.